Abstract
The genetic analysis of the Dengue virus circulating in Ethiopia’s Afar region, in 2023, identified three distinct introductions with spatiotemporal clustering linked to genomes from Asia and Italy. These findings are crucial for enhancing prevention and control strategies, reinforcing the necessity to provide sustainable tools for genomic epidemiology in Africa.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [Grants No. INV-034,799 and INV-064464]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. Other sources of funding include the ICGEB CRP to Ethiopia (CRP/ETH21-01) and PNRR GENESIS - COC-1-2023-UNIPV - ID S1.P0002 (INF-ACT). The content and findings reported in this work are the sole responsibility of the researchers involved and do not necessarily reflect the official positions or sentiments of the funding agencies that supported this project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Regional Public Health Research Ethics Review Committee, Ethiopia, approved the study (Ref. NoH/R/T/T/D/07/39).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
